Part I: Minimum Quality Threshold in Preclinical Sepsis Studies (MQTiPSS) for Study Design and Humane Modeling Endpoints.


Journal

Shock (Augusta, Ga.)
ISSN: 1540-0514
Titre abrégé: Shock
Pays: United States
ID NLM: 9421564

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 15 8 2018
medline: 28 2 2020
entrez: 15 8 2018
Statut: ppublish

Résumé

Preclinical animal studies are mandatory before new treatments can be tested in clinical trials. However, their use in developing new therapies for sepsis has been controversial because of limitations of the models and inconsistencies with the clinical conditions. In consideration of the revised definition for clinical sepsis and septic shock (Sepsis-3), a Wiggers-Bernard Conference was held in Vienna in May 2017 to propose standardized guidelines on preclinical sepsis modeling. The participants conducted a literature review of 260 most highly cited scientific articles on sepsis models published between 2003 and 2012. The review showed, for example, that mice were used in 79% and euthanasia criteria were defined in 9% of the studies. Part I of this report details the recommendations for study design and humane modeling endpoints that should be addressed in sepsis models. The first recommendation is that survival follow-up should reflect the clinical time course of the infectious agent used in the sepsis model. Furthermore, it is recommended that therapeutic interventions should be initiated after the septic insult replicating clinical care. To define an unbiased and reproducible association between a new treatment and outcome, a randomization and blinding of treatments as well as inclusion of all methodological details in scientific publications is essential. In all preclinical sepsis studies, the high standards of animal welfare must be implemented. Therefore, development and validation of specific criteria for monitoring pain and distress, and euthanasia of septic animals, as well as the use of analgesics are recommended. A set of four considerations is also proposed to enhance translation potential of sepsis models. Relevant biological variables and comorbidities should be included in the study design and sepsis modeling should be extended to mammalian species other than rodents. In addition, the need for source control (in case of a defined infection focus) should be considered. These recommendations and considerations are proposed as "best practices" for animal models of sepsis that should be implemented.

Identifiants

pubmed: 30106874
doi: 10.1097/SHK.0000000000001243
pmc: PMC6296871
mid: NIHMS1502277
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-22

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM113228
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM072808
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM104323
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM067202
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM115973
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM109779
Pays : United States

Références

Shock. 2004 Jan;21(1):17-25
pubmed: 14676679
Lab Anim. 2016 Dec;50(6):418-426
pubmed: 27909191
J Am Assoc Lab Anim Sci. 2008 Jan;47(1):8-10
pubmed: 18210991
Br J Pharmacol. 2009 Aug;157(7):1250-62
pubmed: 19563534
J Immunol. 2007 Jul 1;179(1):623-30
pubmed: 17579084
Nat Rev Dis Primers. 2016 Jun 30;2:16045
pubmed: 28117397
Am J Respir Crit Care Med. 2003 Mar 1;167(5):764-70
pubmed: 12598218
Comp Med. 2008 Apr;58(2):120-8
pubmed: 18524169
Surg Clin North Am. 1995 Apr;75(2):257-77
pubmed: 7899997
ILAR J. 2013;54(2):234-45
pubmed: 24174445
Pain. 2007 Jul;130(1-2):108-18
pubmed: 17196337
Nat Rev Immunol. 2013 Dec;13(12):862-74
pubmed: 24232462
Nature. 2012 Mar 28;483(7391):531-3
pubmed: 22460880
Circ Res. 2015 Jan 2;116(1):116-26
pubmed: 25552691
Curr Protoc Mouse Biol. 2012 Jun;2:145-165
pubmed: 22822473
Am J Respir Crit Care Med. 2010 Oct 15;182(8):995-1003
pubmed: 20558632
Crit Care Med. 2015 Sep;43(9):e332-40
pubmed: 25962080
Crit Care Med. 2013 Jan;41(1):263-306
pubmed: 23269131
BMC Infect Dis. 2012 Mar 28;12:71
pubmed: 22455545
Physiol Rev. 2013 Jul;93(3):1247-88
pubmed: 23899564
Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):379-88
pubmed: 21805196
J Exp Med. 1991 Apr 1;173(4):1029-32
pubmed: 1826127
Acad Emerg Med. 2003 Jun;10(6):684-7
pubmed: 12782533
BMC Res Notes. 2014 Apr 12;7:233
pubmed: 24725742
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Shock. 2018 Aug;50(2):226-232
pubmed: 28957876
PLoS One. 2009 Nov 30;4(11):e7824
pubmed: 19956596
PLoS Pathog. 2012 Jan;8(1):e1002399
pubmed: 22275862
Intensive Care Med Exp. 2015 Dec;3(1):48
pubmed: 26215812
Crit Care Med. 2010 Mar;38(3):886-93
pubmed: 20009755
Physiol Res. 2006;55(3):291-299
pubmed: 16083301
Crit Care Med. 2003 Apr;31(4):1250-6
pubmed: 12682500
Crit Care. 2014 May 02;18(3):R87
pubmed: 24886954
Stroke. 2016 Oct;47(10):2435-8
pubmed: 27625385
Nat Rev Drug Discov. 2014 Oct;13(10):741-58
pubmed: 25190187
N Engl J Med. 2003 Jan 9;348(2):138-50
pubmed: 12519925
ILAR J. 2017 Jul 1;58(1):90-105
pubmed: 28444204
Shock. 2010 Oct;34(4):369-76
pubmed: 20610941
Shock. 2010 Oct;34(4):420-6
pubmed: 20610942
PLoS One. 2012;7(12):e51457
pubmed: 23251540
Shock. 2018 Oct;50(4):377-380
pubmed: 30106875
Intensive Care Med. 2007 Jun;33(6):1085-93
pubmed: 17457574
Nature. 2014 Mar 27;507(7493):423-5
pubmed: 24678540
Clinics (Sao Paulo). 2007 Jun;62(3):321-6
pubmed: 17589674
Crit Care Med. 1997 Jul;25(7):1115-24
pubmed: 9233735
Crit Care Med. 2014 Jul;42(7):1714-21
pubmed: 24717456
Cochrane Database Syst Rev. 2011 Apr 13;(4):MR000012
pubmed: 21491415
Curr Protoc Mouse Biol. 2011;1:105-122
pubmed: 21686061
JAMA. 2013 Mar 20;309(11):1154-62
pubmed: 23512062
Stroke. 2016 Jan;47(1):267-72
pubmed: 26658439
Nature. 2016 May 25;533(7604):452-4
pubmed: 27225100
JAMA. 2003 Jul 9;290(2):238-47
pubmed: 12851279
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
J Trauma Acute Care Surg. 2018 Feb;84(2):342-349
pubmed: 29251709
Life Sci. 2016 May 1;152:244-8
pubmed: 26596563
J Immunol. 2014 Jan 15;192(2):612-22
pubmed: 24337739
Intensive Care Med Exp. 2017 Dec;5(1):31
pubmed: 28677045
Shock. 2015 Apr;43(4):304-16
pubmed: 25565638
Shock. 2019 Jan;51(1):33-43
pubmed: 29923896
BMC Res Notes. 2016 Feb 16;9:99
pubmed: 26879530
Nat Rev Nephrol. 2018 Feb;14(2):121-137
pubmed: 29225343
ILAR J. 2005;46(2):162-70
pubmed: 15775025
Circ Res. 2017 Jun 9;120(12):1916-1926
pubmed: 28373349
J Pharmacol Toxicol Methods. 2016 May-Jun;79:72-9
pubmed: 26844408
Nat Methods. 2010 Jun;7(6):447-9
pubmed: 20453868
Circ Res. 2017 Sep 1;121(6):e53-e79
pubmed: 28729353
N Engl J Med. 2013 Aug 29;369(9):840-51
pubmed: 23984731
PLoS One. 2014 Jun 06;9(6):e98856
pubmed: 24906117
Shock. 2017 May;47(5):658-660
pubmed: 28410332
Crit Care. 2014 Mar 03;18(2):R42
pubmed: 24589043
Comp Med. 2011 Dec;61(6):492-8
pubmed: 22330575
Trials. 2019 Feb 14;20(1):118
pubmed: 30760329
J Biomed Biotechnol. 2011;2011:357926
pubmed: 21318073
Ann Intensive Care. 2014 Jul 29;4:26
pubmed: 25114829
Sci Rep. 2017 Jul 26;7(1):6622
pubmed: 28747734
Am J Physiol Endocrinol Metab. 2014 Mar;306(6):E592-605
pubmed: 24425761
Shock. 2018 Mar;49(3):249-258
pubmed: 28885387
Crit Care Med. 2010 Aug;38(8):1685-94
pubmed: 20562702
Nature. 2012 Apr 25;484(7395):524-8
pubmed: 22538616
Shock. 2002 Jun;17(6):463-7
pubmed: 12069181
Shock. 2005 Dec;24 Suppl 1:1-6
pubmed: 16374365
J Trauma Acute Care Surg. 2018 Mar;84(3):537-541
pubmed: 29112093
Crit Care. 2014 Jan 14;18(1):R15
pubmed: 24423201
Am J Respir Crit Care Med. 2016 Jul 15;194(2):147-55
pubmed: 27244481
Science. 2017 Sep 29;357(6358):1337-1338
pubmed: 28963232
Anesth Analg. 2009 Jun;108(6):1841-7
pubmed: 19448210
Virulence. 2014 Jan 1;5(1):4-11
pubmed: 24335434
Shock. 2013 Jun;39(6):488-94
pubmed: 23603767
J Thromb Haemost. 2014 Jun;12(6):958-69
pubmed: 24655755
Vet Anaesth Analg. 2014 Nov;41(6):553-66
pubmed: 24962601
JAMA. 2016 Feb 23;315(8):775-87
pubmed: 26903336
PLoS One. 2014 Jan 31;9(1):e87927
pubmed: 24498223
Shock. 2019 Jan;51(1):4-9
pubmed: 29877959
Crit Care. 2012 Sep 13;16(5):152
pubmed: 22971299
Crit Care Med. 2010 Dec;38(12):2401-8
pubmed: 20890192
PLoS Biol. 2016 Jan 04;14(1):e1002331
pubmed: 26726833
J Immunol. 2002 Apr 15;168(8):4070-7
pubmed: 11937566
PLoS Biol. 2014 Jan;12(1):e1001756
pubmed: 24409096
Cytokine. 2006 Apr;34(1-2):76-84
pubmed: 16737821
Crit Care Med. 2016 Feb;44(2):275-81
pubmed: 26584195
Shock. 2017 Jul;48(1):78-84
pubmed: 27984521
JAMA. 2011 Dec 21;306(23):2614-5
pubmed: 22187284
Crit Care Med. 2005 Oct;33(10):2332-8
pubmed: 16215389
Shock. 2010 Sep;34(3):250-60
pubmed: 20803785
J Am Assoc Lab Anim Sci. 2012 May;51(3):357-65
pubmed: 22776195
PLoS One. 2014 Jun 19;9(6):e100631
pubmed: 24945834
FASEB J. 2018 Feb;32(2):728-741
pubmed: 28974562
J Vis Exp. 2013 Dec 24;(82):51012
pubmed: 24429701
J Immunol. 2017 Jul 15;199(2):383-388
pubmed: 28696328
Transplantation. 2012 Dec 27;94(12):1187-91
pubmed: 23128998
Shock. 2019 Jan;51(1):23-32
pubmed: 30106873
J Trauma Acute Care Surg. 2014 Mar;76(3):582-92, discussion 592-3
pubmed: 24553523
Crit Care Med. 2001 Jan;29(1):13-7
pubmed: 11176151
Vet Pathol. 2012 Mar;49(2):344-56
pubmed: 21441112
J Neuroimmune Pharmacol. 2011 Dec;6(4):551-65
pubmed: 21826405
Animals (Basel). 2014 Jun 19;4(2):361-73
pubmed: 26480045
Nature. 2016 Apr 28;532(7600):512-6
pubmed: 27096360
J Gerontol A Biol Sci Med Sci. 2000 Mar;55(3):B117-23
pubmed: 10795715
Shock. 2000 Feb;13(2):110-6
pubmed: 10670840
Shock. 2014 Jun;41(6):463-75
pubmed: 24569509
Int J Mol Sci. 2017 Aug 10;18(8):
pubmed: 28796194
Crit Care Med. 2016 Jun;44(6):e420-31
pubmed: 26862708
Sci Transl Med. 2015 Aug 5;7(299):299ra121
pubmed: 26246166
PLoS Biol. 2015 Oct 13;13(10):e1002273
pubmed: 26460723
Crit Care. 2011;15(1):R3
pubmed: 21211004
Lab Anim. 2011 Jan;45(1):1-13
pubmed: 21123303
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3507-12
pubmed: 23401516
Eur Cell Mater. 2014 Mar 25;27:196-212
pubmed: 24668594
J Am Assoc Lab Anim Sci. 2017 May 1;56(3):307-317
pubmed: 28535866
Crit Care Med. 2016 Aug;44(8):1461-7
pubmed: 26992066
J Immunol. 2012 Nov 1;189(9):4648-56
pubmed: 23008446
Crit Care Med. 2018 May;46(5):e426-e434
pubmed: 29369056
Intensive Care Med Exp. 2017 Dec;5(1):23
pubmed: 28429311
Shock. 2003 Apr;19(4):310-3
pubmed: 12688540
BMJ. 2018 Jan 10;360:j5845
pubmed: 29321165
J Surg Res. 2013 May 1;181(1):129-35
pubmed: 22739046
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591
Aging Dis. 2014 Apr 01;5(2):126-36
pubmed: 24729938
ILAR J. 2000;41(2):72-9
pubmed: 11406700
EMBO J. 2014 Nov 18;33(22):2597
pubmed: 25342857
Lab Anim (NY). 2015 Mar;44(3):106-10
pubmed: 25693108
Crit Care Med. 2009 May;37(5):1567-73
pubmed: 19325479
Cardiovasc Eng Technol. 2015 Mar;6(1):2-7
pubmed: 26577097

Auteurs

Basilia Zingarelli (B)

Department of Pediatrics, Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, College of Medicine, University of Cincinnati, Cincinnati, Ohio.

Craig M Coopersmith (CM)

Emory University School of Medicine, Atlanta, Georgia.

Susanne Drechsler (S)

Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in the AUVA Research Center, Vienna, Austria.

Philip Efron (P)

Sepsis and Critical Illness Research Center, University of Florida College of Medicine, Gainesville, Florida.

John C Marshall (JC)

Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, Canada.

Lyle Moldawer (L)

Sepsis and Critical Illness Research Center, University of Florida College of Medicine, Gainesville, Florida.

W Joost Wiersinga (WJ)

Division of Infectious Diseases, Center for Experimental and Molecular Medicine, The Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Xianzhong Xiao (X)

Xiangya School of Medicine, Central South University, Chagnsha, Hunan, China.

Marcin F Osuchowski (MF)

Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in the AUVA Research Center, Vienna, Austria.

Christoph Thiemermann (C)

The William Harvey Research Institute, Barts and London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH